Published
8 months agoon
By
adminWe are selling 300 shares of Bristol Myers Squibb at roughly $47.66. Following the trade, Jim Cramer’s Charitable Trust will own 1,400 shares of BMY, decreasing its weighting to about 1.75% from about 2.15%. Bristol Myers Squibb shares are up roughly 8% over the past two trading sessions, part of a significant relief rally in large-cap drug stocks. The catalyst was a deal between pharma peer Pfizer and the Trump administration that covers most-favored nation drug pricing, domestic manufacturing, and an exemption from pharmaceutical-specific tariffs for a period of three years. Other companies are expected to use the framework of Pfizer’s agreement as a blueprint for more deals. The news was a relief for drug-stock investors because the group had been capped by two significant overhangs — drug pricing policy proposals and tariffs — that threatened earnings. But, as the terms of the deal were announced, the market quickly realized Pfizer’s impact from most-favored nation pricing is expected to be immaterial, and the three-year grace period on tariffs gives the company time to stand up its new domestic manufacturing plants. We’re taking advantage of this recent strength to trim our position in Bristol Myers at a disappointing loss of about 20% on stock purchased in November 2024. We prefer to trim Bristol Myers over our other drugmaker in Eli Lilly because Bristol Myers is more of a show-me story that hinges on successful trials of Cobenfy, its new schizophrenia treatment. As we unfortunately saw earlier this year, drug trials are never guaranteed to be successful, which makes this trim serve as a hedge in case forthcoming studies do not live up to expectations. Additionally, Eli Lilly should be quicker to strike a deal because its long-standing manufacturing push in the U.S. has the company in good standing with the Trump administration. We also remain bullish on next year’s launch of its oral GLP-1 orforgliporn. Finally, this sale helps rebuild our cash position, which we’ve used up over the past few weeks while scaling into new names like Boeing and Nike . The outlook for Boeing and Nike are much stronger than Bristol Myers. In effect, this sale Wednesday allows us to raise cash from a losing position that we can redirect into what we believe will be two winners. Earlier Wednesday, we added to our Nike stake after its earnings report reinforced our conviction in the apparel giant’s turnaround plan. (Jim Cramer’s Charitable Trust is long BMY, LLY, BA and NKE. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
This industrial giant is emerging as a big AI play, says Wells Fargo
Novo Nordisk’s strategy tested as investors push back on board revamp
Alibaba plans AI subscriptions, stablecoin-like payments with JPMorgan
UK borrowing costs spike on report government to scrap plans to raise income tax
Trump’s threatened the BBC with a $1B lawsuit: Here’s what’s going on
UBS’s picks for global returns next year
Wells Fargo sees Caterpillar continuing to roar higher, emerging as an artificial intelligence play. The bank initiated shares of...
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic...
Key Points Alibaba plans to use “tokenization” of payments for cross-border transactions in its business-to-business arm. Kuo Zhang, president...
Rachel Reeves, U.K. chancellor of the exchequer, delivers a speech in London, UK, on Tuesday, Nov. 4, 2025. Bloomberg...
US President Donald Trump speaks to reporters as he arrives at Palm Beach International Airport on Oct. 31,...
Investors looking for global diversification opportunities should look to a specific subset of stocks in Europe, according to UBS...
Eakarat Buanoi | Istock | Getty Images LISBON, Portugal — Top tech executives told CNBC they’re concerned about...
Tan Su Shan, deputy chief executive officer and managing director of institutional banking at DBS Group Holdings Ltd., speaks during...
CHENGDU, CHINA – OCTOBER 18: People walk past the Louis Vuitton store at Taikoo Li, a high-end shopping area that...
The United States said Thursday it will remove tariffs on some foods and other imports from Argentina, Ecuador, Guatemala and...
